Literature DB >> 26363522

ERK1, 2, and 5 expression and activation in dopaminergic brain regions during postnatal development.

Mayur S Parmar1, Juliann D Jaumotte2, Michael J Zigmond2, Jane E Cavanaugh3.   

Abstract

Degeneration and dysfunctioning of dopaminergic neurons in the midbrain have been associated with serious neurodegenerative and neuropsychiatric disorders. Elucidating the underlying neurobiology of these neurons during early postnatal development may provide important information regarding the etiology of these disorders. Cellular signaling pathways have been shown to regulate postnatal neuronal development. Among several signaling pathways, extracellular-regulated mitogen kinases (ERK) 1, 2, and 5 have been shown to be crucial for the survival and function of dopaminergic neurons. In this study, the basal expression and activation of ERK1, 2, and 5 were studied during postnatal development in regions rich in DA cells and terminals. In the striatum (STR) and ventral mesencephalon regions of the substantia nigra (SN) and ventral tegmental area (VTA), ERK5 expression and activation were high during early postnatal days and declined with aging. Interestingly, sharp increases in phosphorylated or activated ERK1 and ERK2 were observed at postnatal day (PND) 7 in the SN and VTA. In contrast, in the STR, the levels of phosphorylated ERK1 and 2 were significantly higher at PND0 than at any other PND examined. Overall, the understanding of alterations in ERK signaling in regions rich in DA cells and DA terminals during postnatal neuronal development may provide information about their role in regulation of dopamine neuronal development which may ultimately provide insight into the underlying mechanisms of dopamine neurodegeneration.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine neurons; MAP kinases; Striatum; Substantia nigra; Ventral tegmental area

Mesh:

Substances:

Year:  2015        PMID: 26363522     DOI: 10.1016/j.ijdevneu.2015.06.009

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  4 in total

1.  Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism.

Authors:  Erika N Allen; Sneha Potdar; Victor Tapias; Mayur Parmar; Cassia S Mizuno; Agnes Rimando; Jane E Cavanaugh
Journal:  J Nutr Biochem       Date:  2017-11-04       Impact factor: 6.048

2.  Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model.

Authors:  Onat Akyol; Prativa Sherchan; Gokce Yilmaz; Cesar Reis; Wingi Man Ho; Yuechun Wang; Lei Huang; Ihsan Solaroglu; John H Zhang
Journal:  Exp Neurol       Date:  2018-06-05       Impact factor: 5.330

Review 3.  Milk's Role as an Epigenetic Regulator in Health and Disease.

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Diseases       Date:  2017-03-15

4.  Nox2 contributes to age-related oxidative damage to neurons and the cerebral vasculature.

Authors:  Lampson M Fan; Li Geng; Sarah Cahill-Smith; Fangfei Liu; Gillian Douglas; Chris-Anne Mckenzie; Colin Smith; Gavin Brooks; Keith M Channon; Jian-Mei Li
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.